Capacite Infraprojects Secures ₹306 Crore Award From Puravankara Limited
Capacite Infraprojects has been awarded a ₹306 crore contract by Puravankara Limited to construct a residential building with retail space in Andheri West, Mumbai. Meanwhile, Q2 consolidated net profit came in at ₹47.7 crore versus ₹49.1 crore YoY.
Market snapshot: Capacite Infraprojects has secured a letter of award worth ₹306 crore from Puravankara Limited for a residential project in Andheri West, Mumbai. Alongside the new order inflow, the company reported a consolidated net profit of ₹47.7 crore for Q2, compared to ₹49.1 crore in the corresponding prior-year period.
Data Snapshot
- Letter of Award from Puravankara Limited worth ₹306 crore for the Estrella residential project in Andheri West, Mumbai, comprising 3 basements, 25 residential floors, and retail space.
- Q2 consolidated net profit reported at ₹47.7 crore compared to ₹49.1 crore in the year-ago period.
What's Changed
- New order win: ₹306 crore residential EPC project added to the execution pipeline.
- Q2 consolidated net profit: ₹47.7 crore vs ₹49.1 crore in the corresponding prior period.
Key Takeaways
- Capacite Infraprojects secured a ₹306 crore Letter of Award from Puravankara Limited.
- The scope encompasses the Estrella residential project in Andheri West, Mumbai, including 3 basements, 25 residential floors, clubhouse, and retail space.
- Q2 consolidated net profit registered at ₹47.7 crore against ₹49.1 crore in the year-ago quarter.
SAHI Perspective
The ₹306 crore contract intake from Puravankara reinforces Capacite Infraprojects' position as a key EPC contractor for complex high-rise residential developments in premier Mumbai micro-markets. Although Q2 consolidated net profit saw a modest YoY contraction to ₹47.7 crore from ₹49.1 crore, steady order backlog expansion strengthens top-line visibility over upcoming execution cycles.
Market Implications
Contract inflows in high-density urban corridors enhance order book density for specialized civil construction firms. Securing repeat mandates from established real estate developers like Puravankara provides revenue stability, helping offset marginal quarterly profit variations.
Trading Signals
Market Bias: Bullish
Substantial ₹306 crore contract win strengthens the company's execution order book despite Q2 consolidated net profit moderating slightly to ₹47.7 crore from ₹49.1 crore YoY.
Overweight: Real Estate EPC, Urban Building Construction
Trigger Factors:
- Project site mobilization and execution progress at Andheri West
- Sustained quarterly revenue milestone recognition
- Working capital and cash conversion cycle management
Time Horizon: Medium-term (3-12 months)
Industry Context
India's Tier-1 urban real estate markets continue to drive demand for specialized high-rise and mixed-use civil construction services, enabling established EPC contractors to capture high-value residential projects.
Key Risks to Watch
- Execution delays or structural foundation challenges associated with multi-level basement construction.
- Raw material price volatility in steel and cement impacting operating margins.
- Working capital stretch during site setup and mobilization phases.
Recent Developments
No verified developments in this window
Closing Insight
With a fresh ₹306 crore award in Mumbai's residential corridor, Capacite Infraprojects continues to build execution scale across core high-rise urban projects.
High Performance Trading with SAHI.
Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.
Open Free AccountRelated
Biocon Targets Stronger H2 FY27 Driven By Expanded Insulin Production Capacity
Arman Financial Services Reports Q2 Consolidated Net Profit of ₹51.5 Crore vs ₹8 Crore YoY
Dr Lal PathLabs Reports Q2 Consolidated Net Profit Of ₹1.9 Billion
Marksans Pharma Q2 Consolidated Net Profit Rises To ₹1.41B From ₹983M YoY
Recent
Biocon Targets Stronger H2 FY27 Driven By Expanded Insulin Production Capacity
Arman Financial Services Reports Q2 Consolidated Net Profit of ₹51.5 Crore vs ₹8 Crore YoY
Dr Lal PathLabs Reports Q2 Consolidated Net Profit Of ₹1.9 Billion
Marksans Pharma Q2 Consolidated Net Profit Rises To ₹1.41B From ₹983M YoY
JTEKT India Reports Q2 Standalone Net Profit Of ₹17.5 Crore Vs ₹18.2 Crore YoY
Frequently Asked Questions (FAQs)
All topics
Click the link, confirm the box next to sahi.com is checked — ignore any other results.